Optometrists in Riverdale, MD Accepting Medicare

7 Optometrists found. Showing 1 - 7

Crystal Unhe Kang, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4530 Van Buren Street, Riverdale, MD 20737 Phone: 301-559-0090

Isee Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6615 Riverdale Rd, Riverdale, MD 20737 Phone: 301-918-0095    Fax: 410-874-8599

Gem Optical, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 6603 Riverdale Rd, Riverdale, MD 20737 Phone: 301-918-0095    Fax: 301-918-0097

Gail Ann Petersen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6615 Riverdale Rd, Riverdale, MD 20737 Phone: 301-918-0095    Fax: 301-918-0097

Dr. Julene Tina Pena, O.D., F.A.A.O. Optometrist - Low Vision Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6200 Baltimore Avene, Suite 100, Riverdale, MD 20737 Phone: 240-737-5160

Dr. Rajini Seevaratnam, O.D., M.SC Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5711 Sarvis Ave Ste 402, Riverdale, MD 20737 Phone: 301-277-4844    Fax: 301-927-3221

Dr. Phillip M Liggins, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 5711 Sarvis Ave, Ste 402, Riverdale, MD 20737 Phone: 301-277-4844    Fax: 301-927-3221

News Archive

Neuroscientists identify specific enzyme that plays critical role in spinal muscular atrophy

Neuroscientists have discovered a specific enzyme that plays a critical role in spinal muscular atrophy, and that suppressing this enzyme's activity, could markedly reduce the disease's severity and improve patients' lifestyles.

Trans-fatty acids promote cell death in a more direct manner than previously thought

Tohoku University researchers have found that trans-fatty acids promote cell death in a more direct manner than previously thought, leading to the development of atherosclerosis, a major cause of heart attacks and strokes.

Mutated gene causes serious heart disease in newborns

The research group of professor Manfred Kilimann at the Department of Cell and Molecular Biology has elucidated the genetic cause of a severe heart disease in newborn children. This result will be published in the June issue of the American Journal of Human Genetics this week.

Theraclone initiates TCN-032 Phase 1 trial in influenza A

Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, announced today first dosing of subjects in a Phase 1 clinical trial of TCN-032, a broadly protective, fully human monoclonal antibody for the treatment of influenza A virus.

Read more Medical News

› Verified 3 days ago